PYPD (PolyPid Ltd.) Stock Market Reviews

crown

search

Read and share opinions on PYPD (PolyPid Ltd.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

PYPD

PolyPid Ltd.

clarify Biotechnology

bookmark Healthcare

public Israel

Sell Neutral Buy

Latest News

PolyPid Ltd (PYPD) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges
Nov 12, 2025
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Nov 12, 2025
PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
Nov 6, 2025
PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
Oct 29, 2025
PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress
Sep 30, 2025
PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference
Sep 17, 2025
PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀
Sep 16, 2025
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Sep 3, 2025
PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference
Sep 2, 2025
PolyPid Ltd (PYPD) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Rising Expenses
Aug 14, 2025
PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
Aug 12, 2025
PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025
Jul 30, 2025
PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits
Jul 16, 2025
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
Jun 9, 2025

Reviews